FDA Authorizes New Long-Acting Monoclonal Antibodies (AZD7442 or EVUSHELD) for Pre-exposure Prevention of COVID-19 in Certain Individuals

[nkclimbs]

CLL Society is excited to share the news that the monoclonal antibody treatment AZD7442 has just been approved for pre-exposure prevention of COVID19!

It is only available for certain individuals, and CLL Society worked hard to ensure that those "certain individuals" with access to this passive immunity were the most vulnerable patients, namely the immunocompromised, including those with CLL/SLL.

This is the great news we have been waiting for. It could change everything for CLL/SLL patients by giving them adequate protection against COVID19.

Read the FDA press release here: fda.gov/news-events/press-a...

[thompsonellen]

Just say this in the NY Times. This is really great news! Thanks to the CLL Society for advocating for us.

[Jm954 Administrator]

I really hope the UK NHS can progress something like this for people with blood cancer or at least those that have been tested and have no antibodies.Jackie

[Pinkdark2018 in reply to Jm954]

I hope this rolls out for all those with Cll by the nhs and not divide us up any further!

[MaxSmart]

Thanks NK. How do I get this? What do I need to do to get this?

[nvrbeold62]

This is great news for sure! I'm calling my hem-onc today.

[Luap001]

This is what the immune compromised have been waiting for. No more worries about whether you are responsive to the vaccine! BTW, I am 4 months post Regeneron treatment and my anti-COVID antibody level remains very high. In fact, it has not diminished at all since it was administered! This gives me a lot of confidence in the durability of the protection provided by monoclonal antibodies treatments. I wear no mask and visit a gym regularly and I am fine. I am proof it works well! Eventually, the Regeneron will wane and, when it does, I will get EvuShield. Nice that it is an injection versus an infusion. Frankly, since this is a jab, I don’t understand why this cannot be made available to anyone. I am sure that an unrestricted approval would lead to volume production. Give people a choice. What if this works better than the “vaccines” which are likely to continue to require regular boosters and still they don’t stop the spread or assuredly prevent inspection (although they reduce deaths)? BTW, fluvoxamine has an amazing ability to reduce death among the infected. And it’s cheap! EvuShield’s protection is supposed to last about a year. Does it stop the spread? Well, if it stops the infection assuredly, I suppose it would. Time and observation will tell.

[SeymourB]

I've called infusion centers at a couple of hospitals here in New Orleans. They haven't heard of this yet. I imagine it will take awhile to transition from the trial to shipping production quantities.

In the U.S., if you or someone you live with tests positive, you can still get the REGEN-COV Regeneron cocktail. Don't wait for Evusheld to ship. Every day counts.

The web sites for post-exposure REGEN-COV infusions are not at all accurate, so call around to local hospitals now before you need an infusion. The CLL Society has a great checklist of things to collect before you get exposed or infected so there's less panic:

cllsociety.org/2021/07/covi...

That checklist is probably good for people outside the U.S., too, with only slight modifications.